Related references
Note: Only part of the references are listed.Metabolic rewiring in melanoma
B. I. Ratnikov et al.
ONCOGENE (2017)
Oncogene KRAS activates fatty acid synthase, resulting in specific ERK and lipid signatures associated with lung adenocarcinoma
Arvin M. Gouw et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Macroautophagy is dispensable for growth of KRAS mutant tumors and chloroquine efficacy
Christina H. Eng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Glutamine transporters in mammalian cells and their functions in physiology and cancer
Yangzom D. Bhutia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer
Shawn M. Davidson et al.
CELL METABOLISM (2016)
Relationship Between 18F-Fluorodeoxyglucose Uptake and V-Ki-Ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Mutation in Colorectal Cancer Patients Variability Depending on C-Reactive Protein Level
Jae-Hoon Lee et al.
MEDICINE (2016)
Arginine Methylation of MDH1 by CARM1 Inhibits Glutamine Metabolism and Suppresses Pancreatic Cancer
Yi-Ping Wang et al.
MOLECULAR CELL (2016)
A combinatorial strategy for treating KRAS-mutant lung cancer
Eusebio Manchado et al.
NATURE (2016)
Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers
Jared R. Mayers et al.
SCIENCE (2016)
The role of wild type RAS isoforms in cancer
Bingying Zhou et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2016)
Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor
Abigail S. Krall et al.
NATURE COMMUNICATIONS (2016)
Vitamin C uncouples the Warburg metabolic switch in KRAS mutant colon cancer
Oscar Aguilera et al.
ONCOTARGET (2016)
Metabolic Adaptation to Nutritional Stress in Human Colorectal Cancer
Masaaki Miyo et al.
SCIENTIFIC REPORTS (2016)
Fatty Acid Oxidation Mediated by Acyl-CoA Synthetase Long Chain 3 Is Required for Mutant KRAS Lung Tumorigenesis
Mahesh S. Padanad et al.
CELL REPORTS (2016)
Metabolic Alterations Caused by KRAS Mutations in Colorectal Cancer Contribute to Cell Adaptation to Glutamine Depletion by Upregulation of Asparagine Synthetase
Kosuke Toda et al.
NEOPLASIA (2016)
Mechanisms underlying 18F-fluorodeoxyglucose accumulation in colorectal cancer
Kenji Kawada et al.
WORLD JOURNAL OF RADIOLOGY (2016)
Amino Acid Transporters in Cancer and Their Relevance to Glutamine Addiction: Novel Targets for the Design of a New Class of Anticancer Drugs
Yangzom D. Bhutia et al.
CANCER RESEARCH (2015)
The Utilization of Extracellular Proteins as Nutrients Is Suppressed by mTORC1
Wilhelm Palm et al.
CELL (2015)
Metabolic Dependencies in RAS-Driven Cancers
Alec C. Kimmelman
CLINICAL CANCER RESEARCH (2015)
Relationship Between 18F-FDG PET/CT Scans and KRAS Mutations in Metastatic Colorectal Cancer
Kenji Kawada et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance
Dohoon Kim et al.
NATURE (2015)
The consensus molecular subtypes of colorectal cancer
Justin Guinney et al.
NATURE MEDICINE (2015)
Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH
Jihye Yun et al.
SCIENCE (2015)
Targeting cancer cell metabolism in pancreatic adenocarcinoma
Romain Cohen et al.
ONCOTARGET (2015)
Functional genomic screening reveals asparagine dependence as a metabolic vulnerability in sarcoma
Simone Hettmer et al.
ELIFE (2015)
Combined autophagy and HDAC inhibition A phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors
Devalingam Mahalingam et al.
AUTOPHAGY (2014)
A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme
Myrna R. Rosenfeld et al.
AUTOPHAGY (2014)
Correlation Between PET/CT Parameters and KRAS Expression in Colorectal Cancer
Shang-Wen Chen et al.
CLINICAL NUCLEAR MEDICINE (2014)
The mTORC1/S6K1 Pathway Regulates Glutamine Metabolism through the elF4B-Dependent Control of c-Myc Translation
Alfredo Csibi et al.
CURRENT BIOLOGY (2014)
Role of [18F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer
Carlos Caicedo et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Regulation of F-18-FDG Accumulation in Colorectal Cancer Cells with Mutated KRAS
Masayoshi Iwamoto et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Multifunctional Imaging Signature for V-KI-RAS2 Kirsten Rat Sarcoma Viral Oncogene Homo log (KRAS) Mutations in Colorectal Cancer
Kenneth A. Miles et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Asparagine Plays a Critical Role in Regulating Cellular Adaptation to Glutamine Depletion
Ji Zhang et al.
MOLECULAR CELL (2014)
Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development
Jared R. Mayers et al.
NATURE MEDICINE (2014)
Phase II and Pharmacodynamic Study of Autophagy Inhibition Using Hydroxychloroquine in Patients With Metastatic Pancreatic Adenocarcinoma
Brian M. Wolpin et al.
ONCOLOGIST (2014)
KRAS: feeding pancreatic cancer proliferation
Kirsten L. Bryant et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
Asparagine synthetase: regulation by cell stress and involvement in tumor biology
Mukundh N. Balasubramanian et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer
Krushna C. Patra et al.
CANCER CELL (2013)
Exploiting the bad eating habits of Ras-driven cancers
Eileen White
GENES & DEVELOPMENT (2013)
Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis
Jessie Yanxiang Guo et al.
GENES & DEVELOPMENT (2013)
Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells
Cosimo Commisso et al.
NATURE (2013)
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Jaekyoung Son et al.
NATURE (2013)
Metabolic targets for cancer therapy
Lorenzo Galluzzi et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids
Jurre J. Kamphorst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A sulfoximine-based inhibitor of human asparagine synthetase kills L-asparaginase-resistant leukemia cells
Hideyuki Ikeuchi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
Haoqiang Ying et al.
CELL (2012)
Relationship between 18F-Fluorodeoxyglucose Accumulation and KRAS/BRAF Mutations in Colorectal Cancer
Kenji Kawada et al.
CLINICAL CANCER RESEARCH (2012)
Pancreatic Tumor Sensitivity to Plasma L-Asparagine Starvation
Emmanuelle Dufour et al.
PANCREAS (2012)
Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation
Mohit Jain et al.
SCIENCE (2012)
Deconvoluting the context-dependent role for autophagy in cancer
Eileen White
NATURE REVIEWS CANCER (2012)
Pancreatic cancers require autophagy for tumor growth
Shenghong Yang et al.
GENES & DEVELOPMENT (2011)
Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis
Jessie Yanxiang Guo et al.
GENES & DEVELOPMENT (2011)
Otto Warburg's contributions to current concepts of cancer metabolism
Willem H. Koppenol et al.
NATURE REVIEWS CANCER (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation
Jiangbin Ye et al.
EMBO JOURNAL (2010)
Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer
R. J. DeBerardinis et al.
ONCOGENE (2010)
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Frank Weinberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Autophagy and Metabolism
Joshua D. Rabinowitz et al.
SCIENCE (2010)
Glutamine addiction: a new therapeutic target in cancer
David R. Wise et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
18F-FDG Uptake in Lung, Breast, and Colon Cancers: Molecular Biology Correlates and Disease Characterization
Hossein Jadvar et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells
Jihye Yun et al.
SCIENCE (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab
Astrid Lievre et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Ras oncogenes: split personalities
Antoine E. Karnoub et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Molecular origins of cancer: Lung cancer
Roy S. Herbst et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
K-ras mutations and benefit from cetuximab in advanced colorectal cancer
Christos S. Karapetis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Amino acid transporters ASCT2 and LAT1 in cancer: Partners in crime?
BC Fuchs et al.
SEMINARS IN CANCER BIOLOGY (2005)
Cancer genes and the pathways they control
B Vogelstein et al.
NATURE MEDICINE (2004)
Share Paper
